Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity

v3.19.3.a.u2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-controlling Interest
Balance at period start (in shares) at Dec. 31, 2016   (55,642,686) (12,402,119)        
Balance at period start at Dec. 31, 2016 $ 413,287 $ 278 $ (33,068) $ 516,675 $ (422) $ (70,574) $ 398
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   837,857          
Exercise of stock options 7,951 $ 4   7,947      
Issuance of common stock - vesting of restricted stock units (in shares)   969,513          
Issuance of common stock - vesting of restricted stock units 5 $ 5          
Stock-based compensation expense 31,635     31,635      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (347,296)        
Purchase of treasury stock for stock-based tax withholdings (13,974)   $ (13,974)        
Foreign currency translation gains (losses), net 1,046       1,046    
Net income (loss) (3,280)         (3,280)  
Balance at period end at Dec. 31, 2017 436,670 $ 287 $ (47,042) 556,257 624 (73,854) 398
Balance at period end (in shares) at Dec. 31, 2017   (57,450,056) (12,749,415)        
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   359,345          
Exercise of stock options 5,305 $ 2   5,303      
Issuance of common stock - vesting of restricted stock units (in shares)   1,073,681          
Issuance of common stock - vesting of restricted stock units 4 $ 4          
Stock-based compensation expense 40,245     39,969     276
Purchase of treasury stock for stock-based tax withholdings (in shares)     (367,683)        
Purchase of treasury stock for stock-based tax withholdings (20,816)   $ (20,816)        
Issuance of non-controlling units in private company 473           473
Issuance of Convertible Notes due 2023, net of offering costs 46,611     46,611      
Issuance of common stock - private placement (in shares)   2,355,816          
Issuance of common stock and warrants - private placement, net of offering costs 118,161 $ 13   118,148      
Purchase of non-controlling units in ERS (6,560)     (5,160)     (1,400)
Reclassification of redeemable units 900           900
Foreign currency translation gains (losses), net (1,618)       (1,618)    
Net income (loss) 4,010         5,755 (1,745)
Balance at period end at Dec. 31, 2018 632,602 $ 306 $ (67,858) 761,128 (994) (58,882) (1,098)
Balance at period end (in shares) at Dec. 31, 2018   (61,238,898) (13,117,098)        
Increase (decrease) in shareholders' equity              
Exercise of stock options (in shares)   783,216          
Exercise of stock options 10,592 $ 4   10,588      
Issuance of common stock - vesting of restricted stock units (in shares)   1,098,124          
Issuance of common stock - vesting of restricted stock units 5 $ 5          
Acquisition of business (in shares)   3,200,468          
Acquisition of business 223,256 $ 16   223,240      
Stock-based compensation expense 54,436     54,436      
Purchase of treasury stock for stock-based tax withholdings (in shares)     (361,902)        
Purchase of treasury stock for stock-based tax withholdings (23,107)   $ (23,107)        
Issuance of non-controlling units in private company (12,251)     (12,251)      
Foreign currency translation gains (losses), net (755)       (755)    
Net income (loss) (17,202)         (16,782) (420)
Balance at period end at Dec. 31, 2019 $ 867,576 $ 331 $ (90,965) $ 1,037,141 $ (1,749) $ (75,664) $ (1,518)
Balance at period end (in shares) at Dec. 31, 2019   (66,320,706) (13,479,000)